
Psychemedics Corporation PMD
Quarterly report 2024-Q3
added 05-16-2026
Psychemedics Corporation PEG Ratio 2011-2026 | PMD
Annual PEG Ratio Psychemedics Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.0317 | 0.297 | 0.723 | -0.545 | -0.511 | -0.883 | -2.09 | 0.0621 | -0.63 | -1.5 | 0.799 | -1.39 | 0.437 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.799 | -2.09 | -0.4 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
0 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 203.75 | -0.01 % | $ 22.6 B | ||
|
Celcuity
CELC
|
-0.769 | $ 89.67 | 1.62 % | $ 4.19 B | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 4.7 | -3.69 % | $ 6.25 M | ||
|
Fulgent Genetics
FLGT
|
0.21 | $ 18.8 | -0.69 % | $ 579 M | ||
|
Castle Biosciences
CSTL
|
-0.628 | $ 21.11 | 0.14 % | $ 612 M | ||
|
Aspira Women's Health
AWH
|
-0.000244 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.00013 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.000272 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
4.55 | $ 148.67 | 2.82 % | $ 11.7 B | ||
|
Illumina
ILMN
|
2.16 | $ 164.19 | 1.06 % | $ 25.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-3.43 | $ 131.81 | 0.85 % | $ 16.5 B | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 24.05 | 2.51 % | $ 1.28 B | ||
|
Chembio Diagnostics
CEMI
|
-0.0348 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.00301 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 1.65 | -6.41 % | $ 7.3 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.000399 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.0777 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.12 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 103.99 | 3.74 % | $ 7.02 B | ||
|
Pacific Biosciences of California
PACB
|
-0.0332 | $ 1.36 | -1.09 % | $ 408 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 188.58 | 1.32 % | $ 9.35 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 475.73 | 2.15 % | $ 13.7 B | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
4.59 | $ 1 139.74 | 0.59 % | $ 23.5 B | ||
|
NeoGenomics
NEO
|
0.0904 | $ 11.4 | 1.06 % | $ 1.46 B | ||
|
Myriad Genetics
MYGN
|
-0.00985 | $ 4.64 | 4.85 % | $ 430 M | ||
|
National Research Corporation
NRC
|
-7.14 | $ 18.98 | -10.81 % | $ 425 M | ||
|
Natera
NTRA
|
-17.7 | $ 220.54 | 1.87 % | $ 30.2 B | ||
|
Personalis
PSNL
|
-1.05 | $ 9.34 | -2.81 % | $ 834 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.123 | $ 26.24 | 2.14 % | $ 24.9 B | ||
|
Senseonics Holdings
SENS
|
-0.0159 | $ 7.42 | 1.64 % | $ 310 M | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
0.383 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
-2.4 | $ 71.83 | 5.99 % | $ 4.3 B | ||
|
Biomerica
BMRA
|
-0.0105 | $ 2.08 | 2.97 % | $ 4.78 M | ||
|
Laboratory Corporation of America Holdings
LH
|
22.7 | $ 265.04 | -1.34 % | $ 22.1 B | ||
|
Thermo Fisher Scientific
TMO
|
9.76 | $ 476.57 | -1.19 % | $ 180 B | ||
|
Trinity Biotech plc
TRIB
|
-0.637 | $ 0.68 | -1.47 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-0.000026 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 9.3 | 1.36 % | $ 2.02 B | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M |